drugset / Trial / NCT01278095
Oral Bioavailability of GLPG0555 in Different Solid Formulations
RandomizedParallel-groupOpen-label
Summary
The purpose of the study is to compare the pharmacokinetics of a solid capsule formulation of GLPG0555 with a nanosuspension, and to assess safety and tolerability of a single dose of GLPG0555.
Timeline
- Start
- 2011-01
- Primary completion
- 2011-02
- Completion
- 2011-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GLPG0555 | Unknown | 50 mg | — |
Indications
No indication recorded.